Cervical Dysplasia Diagnostic Market - by Diagnostic, and End Users

Cervical infection is major risk factor for progression of HPV. Currently, conventional Pap smear test or HPV test are the only test available for screening cervical infection, which in turn propels the demand for development of DNA-based molecular testing to detect human papillomavirus for diagnosis of cervical cancer. For instance, in 2016, Becton, Dickinson and Company received pre-diagnostic market approval from FDA for its Onclarity HPV assay, type of HPV test. However, current practices for cervical dysplasia diagnostic through colposcopy requires trained professional to perform the test, which is major challenge for growth of the market. To overcome this, research institutes and universities are involved in development of innovative diagnosis devices, which in driving growth of the cervical dysplasia diagnostic market. For instance, in July 2017, Duke University in North Carolina developed a pocket colposcopy device enable with laptop and mobile connection. The device was funded by National Institutes of Health (NIH).

Get The Holistic SAMPLE Of This Business Report:
https://www.coherentmarketinsights.com/insight/request-sample/1486

The untreated cervical dysplasia progresses into cervical cancer or cervical carcinoma, which is the leading cause of cancer death for women in the US. According to American Society of Clinical Oncology (ASCO), in 2017, an estimated 12,820 women in the U.S. are expected to be diagnosed with cervical cancer along with 4210 deaths every year. Furthermore, ASCO reported 68% increase in survival rate of cervical cancer patients, which suggest increasing use of cervical dysplasia diagnostic and boosting cervical dysplasia diagnostic market to prevent the cervical cancer. Moreover, Europe witnessed high prevalence of cervical cancer. For instance, in 2012, the incidence of cervical cancer in Europe was 58348 individuals per millions, increased by rate of 13.4% whereas mortality was raised by 4.9%. Moreover, government organisation of emerging economies are involved in spreading awareness and conducting screening test for cervical dysplasia, which is expected to drive growth of the cervical dysplasia diagnostic market. Organisations such as National Health Service (NHS) offers cervical screening programmes since 1980s, at the interval of every three year for women of age group 25 to 64 year and every five year above 64 in England, wales and northern Ireland.

On the basis of region, cervical dysplasia diagnostic market is segmented into North America, Europe, Asia Pacific, South America, and Middle East. Increasing awareness regarding cervical dysplasia screening programs and technological advancements in screening are the key factors fuelling growth of the North America cervical dysplasia diagnostic market. Moreover, market in Asia Pacific region is expected to witness significant growth over the forecast period, owing to increasing government funding for cervical research and improving healthcare infrastructure.

Download The PDF Brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/1486

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com
Visit our news Website:https://www.coherentwire.com

This release was published on openPR.